Melissa Johns

Director, Financial Planning and Analysis (Acquired by Roche) at Poseida Therapeutics Inc

Melissa Johns Email & Contact Information

Melissa Johns Current Workplace: Poseida Therapeutics Inc

Location:

9390 Towne Centre Dr

Description:

Biotechnology Research,Commercial Physical Research,Genome Engineering,CAR-T cells,Gene Therapy,Gene Editing,piggyBacâ„¢ DNA Modification System,NextGENâ„¢ CRISPR,XTNâ„¢ TALEN,piggyBacâ„¢,Cas-CLOVERâ„¢,TAL-CLOVERâ„¢,Cell Therapy,Adoptive Cell Therapy,Multiple Myeloma,Prostate Cancer,Transposon,Non-viral,Biotechnology,Immunotherapy,Regenerative Medicine,T-cells,Allogeneic,Oncology,Immuno-oncology,Immunology,Poseida,Cytotoxic T Lymphocytes,piggyBacÂ®,cas CLOVERâ„¢,tal CLOVERâ„¢,piggyBacÂ® DNA Modification System,B2B,B2C,Biotech,SaaS,Commercial Physical Research,Biotech Pharmaceuticals Read More

Industry:

Biotechnology Research